[1]杨洛琦,谢连娣,周莉君.从藏象理论探析糖尿病心肌病[J].陕西中医,2022,(10):1423-1426.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.024]
　YANG Luoqi,XIE Liandi,ZHOU Lijun.Treatment of the diabetic cardiomyopathy based on the Chinese medicine viscera manifestation theory[J].,2022,(10):1423-1426.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.024]
点击复制

从藏象理论探析糖尿病心肌病
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年10期
页码:
1423-1426
栏目:
学术探讨
出版日期:
2022-10-05

文章信息/Info

Title:
Treatment of the diabetic cardiomyopathy based on the Chinese medicine viscera manifestation theory
作者:
杨洛琦1; 谢连娣2; 周莉君1
(1.北京中医药大学,北京 100029; 2.北京中医药大学东方医院,北京 100078)
Author(s):
YANG Luoqi; XIE Liandi; ZHOU Lijun
(Beijing University of Chinese Medicine,Beijing 100029,China)
关键词:
藏象理论;  心血管疾病;  糖尿病心肌病;  辨证论治;  病因病机
Keywords:
Viscera manifestation theory;  Cardiovascular disease;  Diabetes cardiomyopathy;  Syndrome differentiation and treatment;  Etiology and pathogenesis
分类号:
R 587.2
DOI:
DOI:10.3969/j.issn.1000-7369.2022.10.024
文献标志码:
A
摘要:
糖尿病心肌病目前尚无有效的治疗方法,为了改善患者生存质量,探讨运用中医藏象理论论治糖尿病心肌病的可能性。现运用中医藏象理论以及辨证论治等相关理论结合患者主要病情论述糖尿病心肌病的中医治疗,探讨糖尿病心肌病的中医发病机制,为治疗糖尿病心肌病提供一种新的思路。
Abstract:
There is no effective methods to cure diabetic cardiomyopathy,in order to improve patients' quality of life,we search the possibilities of using Chinese medicine viscera manifestation theory to treat it.We combine Chinese medicine viscera manifestation theory with patients' illness to analyze treating ways about diabetic cardiomyopathy.Chinese medicine viscera manifestation theory reveal the Chinese medicine's pathogenesis of diabetic cardiomyopathy,it provides a new treating method.

参考文献/References:

[1] 薛守宇,廉 婷,耿爱民,等.黄芪熟黄散瘀方联合维格列汀与缬沙坦治疗早期糖尿病肾病疗效及对患者血糖和肾功能水平的影响[J].陕西中医,2022,43(2):207-210.
[2] Jia G,Marco VG,Sowers JR.Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy[J].Nat Rev Endocrinol,2016,12(3):144-153.
[3] 薛建军,范 强,杨丽霞,等.糖尿病心肌病发病机制及中医药治疗概述[J].中国实验方剂学杂志,2017,23(22):211-217.
[4] Brindley DN,Kok BP,Kienesberger PC,et al.Shedding light on the enigma of myocardial lipotoxicity:The involvement of known and putative regulators of fatty acid storage and mobilization[J].Am J Physiol Endocrinol Metab,2010,298(5):897-908.
[5] Prabhu SD,Frangogiannis NG.The biological basis for cardiac repair after myocardial infarction:From inflammation to fibrosis[J].Circ Res,2016,119(1):91-112.
[6] 曹志鹏,徐承阳,宋 健,等.糖尿病心肌病发病机制的研究进展[J].中国法医学杂志,2019,34(5):478-482.
[7] 郭 振,樊 迪,唐其柱.活性氧在糖尿病心肌病中的作用机制研究进展[J].解放军医学杂志,2020,45(12):1294-1298.
[8] 李婉娇,李 强.糖尿病心肌病的发病机制及治疗方法研究进展[J].中华老年多器官疾病杂志,2019,18(7):536-539.
[9] 位晨晨,钟 明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,41(2):135-139.
[10] Jia G,Hill MA,Sowers JR.Diabetic cardiomyopathy:An update of mechanisms contributing to this clinical entity[J].Circ Res,2018,122(4):624-638.
[11] 赵 昱,周丽波,董 柳,等.《黄帝内经》消渴相关病名考辨[J].中国中医基础医学杂志,2007,13(8):574-576.
[12] 薛博瑜,吴 伟.中医内科学[M].3版.北京:人民卫生出版社,2016:320.
[13] 杨晓晖,钟柳娜,吕仁和.糖尿病心脏病中医药临床研究述评[J].中国医药学报,2003,18(7):430-434.
[14] 徐梓辉,陈大舜,周世文.糖尿病并发冠心病中医药治疗进展及述评[J].中国中医药信息杂志,2001,8(12):18-20.
[15] 佚 名.黄帝内经?素问[M].北京:中医古籍出版社,1970:70-73.
[16] 马明越,杨 正,王 济,等.国医大师王琦论藏象理论与中医诊疗[J].现代中医临床,2017,24(3):13-15.
[17] 高思华,王 键.中医基础理论[M].北京:人民卫生出版社,2016:61-78.
[18] 陈馨浓,郭晓辰,张军平.“肺朝百脉”理论在缺血性心脏病治疗中的应用[J].中医杂志,2018,59(17):1465-1469.
[19] 陈婷婷,吐尔逊阿依?买买提,陈思宇,等.白藜芦醇调控Sirt1减轻糖尿病心肌缺血再灌注后急性肺损伤相关内质网应激[J].陕西中医,2022,43(4):437-441.
[20] 樊一波,文颖娟,李 蒙,等.以脾胃为中心的葛根相关配伍对糖尿病心肌病大鼠受损心肌线粒体的改善作用[J].陕西中医,2020,41(10):1351-1355.
[21] 周 铭.糖尿病与情志失调[J].时珍国医国药,2008,19(4):1002-1003.
[22] 张仲景.金匮要略[M].北京:中医古籍出版社,1997:36.
[23] 郅扶旻,王岩岩,徐洪涛,等.从“心肾并调”论治糖尿病肾病的思路及方法[J].中医药信息,2021,38(1):5-7.
[24] 马 尧,姜维娜,江 红.降糖通脉方治疗糖尿病心肌病临床观察[J].陕西中医,2017,38(6):710-711.
[25] 倪博然,赵进喜,孟繁章,等.浅谈糖尿病从“脾胃肝肾”论治[J].环球中医药,2021,14(10):1853-1856.

相似文献/References:

[1]周 鑫,孙晓莹,贾礼伊,等.中药单体川芎嗪在疾病治疗中的应用与机制研究进展[J].陕西中医,2022,(4):541.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.034]
　ZHOU Xin,SUN Xiaoying,JIA Liyi,et al.Research progress on application and mechanism of traditional Chinese medicine tetramethylpyrazine in disease treatment[J].,2022,(10):541.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.034]
[2]姜春云,姜 泉,常 甜,等.基于“体脏合痹-瘀”辨治类风湿关节炎合并心血管疾病[J].陕西中医,2025,46(3):372.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.018]
　JIANG Chunyun,JIANG Quan,CHANG Tian,et al.Differentiation and treatment of rheumatoid arthritis combined with cardiovascular diseases based on body dysmorphia-stasis[J].,2025,46(10):372.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.018]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(81273692); 首都卫生发展科研专项(首发2020-2-4203)
更新日期/Last Update: 2022-10-09